, and the purulent inflammatory diseases the development of the novel antibacterial drugs is an important approach to treat and control infections. It is known that derivatives of 3-arylmethyl-1,3,7-triazospiro[4.4]nonane-2,4-dione (compounds of the general formula 1) and their Nbenzoyl derivatives exhibit the moderate antimicrobial activity against the strains of gram-positive and gramnegative bacteria, as well as against fungi [3] . Therefore, the aim of our work was to develop the novel antimicrobial substances with the similar structure from aryl amides of the series of 3-arylmethyl-2,4-dioxo-1,3,7-triazospiro[4.4]nonane-7-carboxylic acids.
Since bacteria may cause pneumonia [3] , meningitis [5] , osteomyelitis [9] , endocarditis [4] , sepsis [5] , and the purulent inflammatory diseases the development of the novel antibacterial drugs is an important approach to treat and control infections. It is known that derivatives of 3-arylmethyl-1,3,7-triazospiro [4.4] nonane-2,4-dione (compounds of the general formula 1) and their Nbenzoyl derivatives exhibit the moderate antimicrobial activity against the strains of gram-positive and gramnegative bacteria, as well as against fungi [3] . Therefore, the aim of our work was to develop the novel antimicrobial substances with the similar structure from aryl amides of the series of 3-arylmethyl-2,4-dioxo-1,3,7-triazospiro [4.4] nonane-7-carboxylic acids.
Experimental Part Chemical Part
All solvents and reagents were obtained from the commercial sources. The NMR-spectra were recorded with a Bruker 170 Avance 500 spectrometer at 500 МHz for NMR 1 Н-spectra and at 125 МHz for NMR 13 С-spectra, the solvent was DMSO-d 6 ; TMS was used as an internal standard. Chromato-mass spectra were recorded using an Agilent 1100 HPLC device equipped with a diode matrix detector and a mass-spectrometer (Agilent LC-MSD SL); a Zorbax SB-C18 column (4.6×15 mm) and an atmospheric pressure chemical ionization (APCI) were used for the analyses. The TLC was performed on the aluminium plates covered with a silica gel (Merck, Kiesgel 60 F-254). The melting points were measured with a Kofler melting point apparatus and were not corrected.
The substituted 3-arylmethyl-1,3,7-triazaspiro[4.4] nonane-2,4-diones (1.1-1.4) were obtained according to the methods previously reported [3] .
The general method for the synthesis of the substituted aryl amides of 3-arylmethyl-2,4-dioxo-1,3,7-triazаspiro[4.4]nonane-7-carboxylic acids (2.1-2.13). Dissolve 1.2 mmol of the corresponding 3-arylmethyl-1,3,7-triazaspiro [4.4] nonane-2,4-dione (1.1-1.4) in 3-4 ml of 2-propanol, and then add 1.44 mmol of the substituted aryl isocyanate. Stir the reaction mixture at room temperature for 12 h. Then filter the precipitate formed and wash with 2-propanol. Recrystallize the purified compounds from ethanol. The inoculum suspension was prepared using a DensiLa-Meter apparatus (made by PLIVA-Lachema, Czech Republic; with the wavelength of 540 nm). The suspension was prepared according to the instruction for the apparatus and the Information letter about innovation in the healthcare system No.163-2006 "Standardization of microbial suspension preparation" (Kyiv). The cultures were synchronized using low temperature conditions (4°С). The inoculum density was 107 cells in 1 ml of the medium and was determined by comparing with McFarland standard [8] . The 18 to 24-hour old culture of the microorganism was used for the test. MuellerHinton agar was used for bacteria. The strain of Candida albicans was cultivated using Sabouraud agar. The experiment was performed using the agar "well" diffusion method [7] . The compounds studied were introduced as 0.3 ml DMSO solution (with the concentration of 100 μg/ml) aliquots. The standards were introduced as the solution in DMSO (30 µg/lm) for Metronidazole and as the water solution (30 µg/lm) for Synthomycine.
Microbiological Experiment

Results and Discussion
The synthesis of the compounds for the antimicrobial activity screening was performed according to Scheme. The starting secondary amines 1 [6] were introduced into the reaction with aryl isocyanates in the 2-propanol medium. The products 2 were precipitated as white amorphous solids.
The structures of the compounds obtained were confirmed using 1 H,
13
C NMR-and chromato-mass spectrometric methods. The data of the instrumental analyses and the melting points for compounds 2 are listed in Tab. 1.
According to the data of Tab. 1 in the 1 H NMR-spectra of compounds 2 the multiplet signals at 2.0-2.4, 3.5-3.6 and 3.6-3.8 ppm produced by the resonance of methylene Table 1 The data of 1 Н,
С NMR-, chromato-mass spectra and the melting points for the substituted aryl amides of 3-arylmethyl-2,4-dioxo-1,3,7-triazospiro [4.4] Continuation of Table 1 The study of the antimicrobial activity for the compounds synthesized was performed using the agar "well" diffusion method. The standard test-strains of gram-positive and gram-negative bacteria, as well as fungi were used according to the international standards [1, 2] . The results of the antibacterial activity screening are presented in Tab. 2.
As it is presented in Tab. 2, almost all compounds tested exhibit the antimicrobial activity against the strains of gram-positive and gram-negative bacteria, as well as against fungi. The fungi of Candida albicans appeared to be the most sensitive for compounds 2, the diameters of the growth inhibition zones in some cases exceeded 20 mm. It should be also mentioned that methyl substitution in the arylmethyl fragment increases the antimicrobial activity against gram-positive bacteria, and it is typical for compounds 2.3 and 2.4.
CONCLUSIONS Using the methodology of the liquid phase combinatorial synthesis the chemical diversity of the available 3-arylmethyl-1,3,7-triazaspiro [4.4] nionane-2,4-diones has been enlarged by the synthesis of the series of novel aryl amides of 3-arylmethyl-2,4-dioxo-1,3,7-triazaspiro [4.4]nonane-7-carboxylic acids. The antimicrobial activity of the compounds obtained has been studied. According to the results of the microbiological screening it has been found that they mostly inhibited the growth of the Candida albicans fungi strain.
